BRUNA SCAGGIANTE

Assistant Professor PhD

University

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Bruna Scaggiante is an Assistant Professor at the University in Italy. Her research focuses on cancer biology and biomarkers, with recent publications investigating the role of circulating cell-free DNA in the diagnosis and treatment monitoring of various cancers, including prostate, ovarian, and breast cancer. She is also exploring new therapeutic targets and challenges in hepatocellular carcinoma and bladder cancer management.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (17)

trombetta carlo

Associate Professor

Università degli Studi di Torino

ITALY

BRUNA SCAGGIANTE

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

LINE-1 266/97 and ALU 260/111 Copy Number Ratios in Circulating Cell-Free DNA in Plasma as Potential Biomarkers for the Detection of Prostate Cancer: A Pilot Case-Control Study

Circulating Tumour DNA for Ovarian Cancer Diagnosis and Treatment Monitoring: What Perspectives for Clinical Use?

Circulating Cell-Free DNA Integrity for Breast and Prostate Cancer: What Is the Landscape for Clinical Management of the Most Common Cancers in Women and Men?

In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells

Plasma Circular RNAs as Biomarkers for Breast Cancer

New challenges in hepatocellular carcinoma: A role for PIWI-interacting RNAs?

Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application?

Editorial: Liquid biopsy in the detection and prediction of outcomes in bladder cancer

Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches

BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets

Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications

A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection

An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer

Cancer management during the COVID-19 world pandemic.

An Overview of siRNA Delivery Strategies for Urological Cancers

High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1&ndash;actin Complex as a New Potential Target for Therapy

Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules

Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells

Collaborators (17)

trombetta carlo

Roberta Bulla

Daniele Generali

GABRIELE GRASSI

Claudio BRANCOLINI

Gabriella Zito

Mario GRASSI

Francesco Claps

Serena Bonin

Gabriele Baj

Alchiede Simonato

Fulvia Felluga

Nicola Pavan

MARIA CATALANO

Riccardo Bartoletti

Giorgia Pastorin

Flavio Rizzolio

Make your next move.

High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1–actin Complex as a New Potential Target for Therapy